{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:07:18Z","timestamp":1794236838073,"version":"4.9.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203823"],"award-info":[{"award-number":["82203823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing medical scientific research project","award":["KJZD-K201900101"],"award-info":[{"award-number":["KJZD-K201900101"]}]},{"name":"Chongqing medical scientific research project","award":["2024ZDXM008"],"award-info":[{"award-number":["2024ZDXM008"]}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["(CSTB2022NSCQ-MSX0477"],"award-info":[{"award-number":["(CSTB2022NSCQ-MSX0477"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-QCXMX0051"],"award-info":[{"award-number":["CSTB2024NSCQ-QCXMX0051"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX1174"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1174"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>N4-acetylcytidine (ac4C) is a novel RNA modification that plays important biological roles in a variety of diseases, including tumors, by regulating gene expression at the posttranscriptional level. As a currently known ac4C-modified \u201cwriting\u201d protein, N-acetyltransferase (NAT10) affects the stability and translation efficiency of target mRNAs by changing the chemical and spatial structure of RNA, thereby acting as an oncogene and tumor suppressor gene in different tumors, highlighting its potential role as a tumor prognostic marker and therapeutic target. Research on the molecular mechanism of ac4C modification and its function in tumors continues to expand, but its action network and clinical translational application still face many challenges. This review systematically explains the molecular mechanism of ac4C modification and its biological significance in tumors and its connection with relevant signaling pathways and the immune microenvironment, focuses on analyzing the research progress of ac4C modification enzymes, and discusses its potential as a tumor target. The purpose of this study was to provide a theoretical basis and new ideas for basic research and the clinical translation of the ac4C modification in the field of oncology.<\/jats:p>","DOI":"10.1186\/s13578-025-01504-9","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:05:02Z","timestamp":1764331502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The function of NAT10-driven N4-acetylcytidine modification in cancer: novel insights and potential therapeutic targets"],"prefix":"10.1186","volume":"15","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuotian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-2690","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"1504_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13059-017-1336-6","volume":"18","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Shi H, He C. Epitranscriptomic influences on development and disease. Genome Biol. 2017;18(1):197.","journal-title":"Genome Biol"},{"issue":"7","key":"1504_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187\u2013200.","journal-title":"Cell"},{"issue":"2","key":"1504_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m6A. Nat Rev Genet. 2021;22(2):119.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"1504_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4161\/rna.7.2.11207","volume":"7","author":"J Karijolich","year":"2010","unstructured":"Karijolich J, Yu YT. Spliceosomal snRNA modifications and their function. RNA Biol. 2010;7(2):192\u2013204.","journal-title":"RNA Biol"},{"issue":"6409","key":"1504_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361(6409):1346\u20139.","journal-title":"Science"},{"issue":"12","key":"1504_CR6","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1261\/rna.063503.117","volume":"23","author":"N Jonkhout","year":"2017","unstructured":"Jonkhout N, Tran J, Smith MA, Schonrock N, Mattick JS, Novoa EM. The RNA modification landscape in human disease. RNA. 2017;23(12):1754\u201369.","journal-title":"RNA"},{"issue":"6","key":"1504_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"40","key":"1504_CR8","doi-asserted-by":"publisher","first-page":"12667","DOI":"10.1021\/jacs.8b06636","volume":"140","author":"JM Thomas","year":"2018","unstructured":"Thomas JM, Briney CA, Nance KD, Lopez JE, Thorpe AL, Fox SD, et al. A chemical signature for cytidine acetylation in RNA. J Am Chem Soc. 2018;140(40):12667\u201370.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1504_CR9","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1038\/s41596-021-00501-9","volume":"16","author":"GS Thalalla","year":"2021","unstructured":"Thalalla GS, Sas-Chen A, Schwartz S, Meier JL. Quantitative nucleotide resolution profiling of RNA cytidine acetylation by ac4C-seq. Nat Protoc. 2021;16(4):2286\u2013307.","journal-title":"Nat Protoc"},{"key":"1504_CR10","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1021\/jacs.1c11985","volume":"144","author":"D Bartee","year":"2022","unstructured":"Bartee D, Nance KD, Meier JL. Site-specific synthesis of N4-acetylcytidine in RNA reveals physiological duplex stabilization. J Am Chem Soc. 2022;144:3487\u201396.","journal-title":"J Am Chem Soc"},{"issue":"22","key":"1504_CR11","doi-asserted-by":"publisher","first-page":"13851","DOI":"10.3390\/ijms232213851","volume":"23","author":"VA Arzumanian","year":"2022","unstructured":"Arzumanian VA, Dolgalev GV, Kurbatov IY, Kiseleva OI. Epitranscriptome review of top 25 most-studied RNA modifications. Int J Mol Sci. 2022;23(22):13851.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1504_CR12","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidi. Mol Cell. 2022;82(15):2797\u2013814.","journal-title":"Mol Cell"},{"issue":"52","key":"1504_CR13","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.C114.602698","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Horikawa S, Suzuki T, Kawauchi H, Tanaka Y, Suzuki T. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA)*. J Biol Chem. 2014;289(52):35724\u201330.","journal-title":"J Biol Chem"},{"issue":"38","key":"1504_CR14","doi-asserted-by":"publisher","first-page":"26201","DOI":"10.1074\/jbc.M114.593996","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Akamatsu Y, Noma A, Kimura S, Miyauchi K, Ikeuchi Y, et al. A single acetylation of 18 S rRNA is essential for biogenesis of the small ribosomal subunit in Saccharomyces cerevisiae. J Biol Chem. 2014;289(38):26201\u201312.","journal-title":"J Biol Chem"},{"key":"1504_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv075","author":"S Sharma","year":"2015","unstructured":"Sharma S, Langhendries J, Watzinger P, K\u00f6tter P. Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1\/THUMPD1. Nucleic Acids Res. 2015. https:\/\/doi.org\/10.1093\/nar\/gkv075.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1504_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00018-023-05107-w","volume":"81","author":"H Zhang","year":"2024","unstructured":"Zhang H, Lu R, Huang J, Li L. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells. Cell Mol Life Sci. 2024;81(1):73.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1504_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","volume":"9","author":"Z Pan","year":"2023","unstructured":"Pan Z, Bao Y, Hu M, Zhu Y, Tan C, Fan L, et al. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma. Cell Death Discov. 2023;9(1):56.","journal-title":"Cell Death Discov"},{"issue":"32","key":"1504_CR18","doi-asserted-by":"publisher","first-page":"2310131","DOI":"10.1002\/advs.202310131","volume":"11","author":"KJ Li","year":"2024","unstructured":"Li KJ, Hong Y, Yu YZ, Xie Z, Lv DJ, Wang C, et al. NAT10 promotes prostate cancer growth and metastasis by acetylating mRNAs of HMGA1 and KRT8. Adv Sci. 2024;11(32):2310131.","journal-title":"Adv Sci"},{"issue":"32","key":"1504_CR19","doi-asserted-by":"publisher","first-page":"2302705","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, et al. NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer. Adv Sci. 2023;10(32):2302705.","journal-title":"Adv Sci"},{"issue":"9","key":"1504_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cac2.12595","volume":"44","author":"H Liu","year":"2024","unstructured":"Liu H, Xu L, Yue S, Su H, Chen X, Liu Q, et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun. 2024;44(9):1018\u201341.","journal-title":"Cancer Commun"},{"issue":"11","key":"1504_CR21","doi-asserted-by":"publisher","first-page":"e7283","DOI":"10.1002\/cam4.7283","volume":"13","author":"Q Guo","year":"2024","unstructured":"Guo Q, Yu W, Tan J, Zhang J, Chen J, Rao S, et al. Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway. Cancer Med. 2024;13(11):e7283.","journal-title":"Cancer Med"},{"key":"1504_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.01.037","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M. The processing, gene regulation, biological functions, and clinical relevance of N4 acetylcytidine on RNA: a systematic review. Mol Ther. 2020. https:\/\/doi.org\/10.1016\/j.omtn.2020.01.037.","journal-title":"Mol Ther"},{"issue":"7","key":"1504_CR23","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1021\/acschembio.9b00369","volume":"14","author":"M Tardu","year":"2019","unstructured":"Tardu M, Jones JD, Kennedy RT, Lin Q, Koutmou KS. Identification and quantification of modified nucleosides in Saccharomyces cerevisiae mRNAs. ACS Chem Biol. 2019;14(7):1403\u20139.","journal-title":"ACS Chem Biol"},{"issue":"7","key":"1504_CR24","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell. 2018;175(7):1872\u201386.","journal-title":"Cell"},{"issue":"17","key":"1504_CR25","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1016\/S0021-9258(17)34590-8","volume":"253","author":"L Stern","year":"1978","unstructured":"Stern L, Schulman LH. The role of the minor base N4-acetylcytidine in the function of the Escherichia coli noninitiator methionine transfer RNA. J Biol Chem. 1978;253(17):6132\u20139.","journal-title":"J Biol Chem"},{"key":"1504_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/nar\/gkj084","volume":"34","author":"S Dunin-Horkawicz","year":"2006","unstructured":"Dunin-Horkawicz S, Czerwoniec A, Gajda MJ, Feder M. A database of RNA modification pathways. Nucleic Acids Res. 2006;34:145.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1504_CR27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/emboj.2009.69","volume":"28","author":"S Chimnaronk","year":"2009","unstructured":"Chimnaronk S, Suzuki T, Manita T, Ikeuchi Y, Yao M, Suzuki T, et al. RNA helicase module in an acetyltransferase that modifies a specific tRNA anticodon. EMBO J. 2009;28(9):1362\u201373.","journal-title":"EMBO J"},{"issue":"4","key":"1504_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbrc.2016.05.124","volume":"476","author":"C Dong","year":"2016","unstructured":"Dong C, Niu L, Song W, Xiong X, Zhang X, Zhang Z, et al. tRNA modification profiles of the fast-proliferating cancer cells. Biochem Biophys Res Commun. 2016;476(4):340\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1504_CR29","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1038\/s41598-024-54197-4","volume":"14","author":"J Gao","year":"2024","unstructured":"Gao J, Xu P, Wang F, Zhang W, Min M, Urba R, et al. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation. Sci Rep. 2024;14(1):3577.","journal-title":"Sci Rep"},{"issue":"2","key":"1504_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cell.2018.06.046","volume":"174","author":"V Davalos","year":"2018","unstructured":"Davalos V, Blanco S, Esteller M. Messenger RNA modifications. Cell. 2018;174(2):498.","journal-title":"Cell"},{"issue":"12","key":"1504_CR31","doi-asserted-by":"publisher","first-page":"e1001247","DOI":"10.1371\/journal.pgen.1001247","volume":"6","author":"CTY Chan","year":"2010","unstructured":"Chan CTY, Dyavaiah M, DeMott MS, Taghizadeh K. A quantitative systems approach reveals dynamic control of tRNA modifications during cellular stress. PLoS Genet. 2010;6(12):e1001247.","journal-title":"PLoS Genet"},{"issue":"6","key":"1504_CR32","doi-asserted-by":"publisher","first-page":"e3000297","DOI":"10.1371\/journal.pbio.3000297","volume":"17","author":"NA Gkatza","year":"2019","unstructured":"Gkatza NA, Castro C, Harvey RF, Hei\u00df M, Popis MC, Blanco S, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17(6):e3000297.","journal-title":"PLoS Biol"},{"issue":"4","key":"1504_CR33","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s44319-024-00098-6","volume":"25","author":"P Kudrin","year":"2024","unstructured":"Kudrin P, Singh A, Meierhofer D, Kusnierczyk A, Orom U. N4-acetylcytidine (ac4C) promotes mRNA localization to stress granules. EMBO Rep. 2024;25(4):1814\u201334.","journal-title":"EMBO Rep"},{"key":"1504_CR34","doi-asserted-by":"crossref","unstructured":"Kudrin PMDVC. Nuclear RNA-acetylation can be erased by the deacetylase SIRT7. BioRxiv. 2021;438707.","DOI":"10.1101\/2021.04.06.438707"},{"issue":"5","key":"1504_CR35","doi-asserted-by":"publisher","first-page":"e738","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022;12(5):e738.","journal-title":"Clin Transl Med"},{"issue":"8","key":"1504_CR36","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.apsb.2022.01.015","volume":"12","author":"R Wei","year":"2022","unstructured":"Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M, et al. NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma. Acta Pharm Sin B. 2022;12(8):3313\u201325.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1504_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.chembiol.2021.07.003","volume":"29","author":"KD Nance","year":"2022","unstructured":"Nance KD, Gamage ST, Alam MM, Yang A, Levy MJ, Link CN, et al. Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA. Cell Chem Biol. 2022;29(2):312\u201320.","journal-title":"Cell Chem Biol"},{"key":"1504_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S. The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol Therapy Nucleic Acids. 2020;20:13\u201324.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"40","key":"1504_CR39","doi-asserted-by":"publisher","first-page":"22232","DOI":"10.1021\/jacs.3c08483","volume":"145","author":"S Yan","year":"2023","unstructured":"Yan S, Lu Z, Yang W, Xu J, Wang Y, Xiong W, et al. Antibody-free fluorine-assisted metabolic sequencing of RNA N4-acetylcytidine. J Am Chem Soc. 2023;145(40):22232\u201342.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"1504_CR40","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.molcel.2024.03.018","volume":"84","author":"H Beiki","year":"2024","unstructured":"Beiki H, Sturgill D, Arango D, Relier S, Schiffers S, Oberdoerffer S. Detection of ac4C in human mRNA is preserved upon data reassessment. Mol Cell. 2024;84(8):1611\u201325.","journal-title":"Mol Cell"},{"issue":"7","key":"1504_CR41","first-page":"79123","volume":"30","author":"S Relier","year":"2024","unstructured":"Relier S, Schiffers S, Beiki H, Oberdoerffer S. Enhanced ac4C detection in RNA via chemical reduction and cDNA synthesis with modified dNTPs. RNA. 2024;30(7):79123\u2013863.","journal-title":"RNA"},{"issue":"9","key":"1504_CR42","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s10620-024-08472-z","volume":"69","author":"S Song","year":"2024","unstructured":"Song S, Li B, Jin X, Li H, Wang H, Wang F, et al. NAT10 overexpression promotes tumorigenesis and epithelial-mesenchymal transition through AKT pathway in gastric cancer. Dig Dis Sci. 2024;69(9):3261\u201375.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1504_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","volume":"42","author":"M Deng","year":"2023","unstructured":"Deng M, Zhang L, Zheng W, Chen J. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. J Exp Clin Cancer Res. 2023;42(1):9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1504_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13046-024-03200-x","volume":"43","author":"G Li","year":"2024","unstructured":"Li G, Ma X, Sui S, Chen Y, Li H, Liu L, et al. NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction. J Exp Clin Cancer Res. 2024;43(1):278.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1504_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12890-024-03463-2","volume":"25","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Li N, Zhu J, Shao C, Zeng X, Yi D. Role of NAT10-mediated ac(4)C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells. BMC Pulm Med. 2025;25(1):75.","journal-title":"BMC Pulm Med"},{"key":"1504_CR46","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.ijbiomac.2022.11.299","volume":"227","author":"W Su","year":"2023","unstructured":"Su W, Xie X, Liu X, Gao D, Ma C, Zulfiqar H, et al. iRNA-ac4C: a novel computational method for effectively detecting N4-acetylcytidine sites in human mRNA. Int J Biol Macromol. 2023;227:1174\u201381.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"1504_CR47","doi-asserted-by":"publisher","first-page":"btae625","DOI":"10.1093\/bioinformatics\/btae625","volume":"40","author":"J Yuan","year":"2024","unstructured":"Yuan J, Wang Z, Pan Z, Li A, Zhang Z, Cui F. DPNN-ac4C: a dual-path neural network with self-attention mechanism for identification of N4-acetylcytidine (ac4C) in mRNA. Bioinformatics. 2024;40(11):btae625.","journal-title":"Bioinformatics"},{"issue":"6","key":"1504_CR48","doi-asserted-by":"publisher","first-page":"168961","DOI":"10.1016\/j.jmb.2025.168961","volume":"437","author":"L Yao","year":"2025","unstructured":"Yao L, Xie P, Dong D, Guo Y, Guan J, Zhang W, et al. Caps-ac4C: an effective computational framework for identifying N4-acetylcytidine sites in human mRNA based on deep learning. J Mol Biol. 2025;437(6):168961.","journal-title":"J Mol Biol"},{"issue":"6","key":"1504_CR49","doi-asserted-by":"publisher","first-page":"168978","DOI":"10.1016\/j.jmb.2025.168978","volume":"437","author":"R Lu","year":"2025","unstructured":"Lu R, Qiao J, Li K, Zhao Y, Jin J, Cui F, et al. ERNIE-ac4C: a novel deep learning model for effectively predicting N4-acetylcytidine sites. J Mol Biol. 2025;437(6):168978.","journal-title":"J Mol Biol"},{"issue":"2","key":"1504_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbrc.2003.09.235","volume":"311","author":"J Lv","year":"2003","unstructured":"Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B. Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun. 2003;311(2):506\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1504_CR51","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S1097-2765(00)00104-0","volume":"6","author":"G Pelletier","year":"2000","unstructured":"Pelletier G, Stefanovsky VY, Faubladier M, Hirschler-Laszkiewicz I, Savard J, Rothblum LI, et al. Competitive recruitment of CBP and Rb-HDAC regulates UBF acetylation and ribosomal transcription. Mol Cell. 2000;6(5):1059\u201366.","journal-title":"Mol Cell"},{"issue":"9","key":"1504_CR52","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1074\/jbc.M110.173393","volume":"286","author":"R Kong","year":"2011","unstructured":"Kong R, Zhang L, Hu L, Peng Q, Han W, Du X, et al. HALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF)*. J Biol Chem. 2011;286(9):7139\u201348.","journal-title":"J Biol Chem"},{"issue":"2","key":"1504_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbrc.2007.06.092","volume":"360","author":"MA Amin","year":"2007","unstructured":"Amin MA, Matsunaga S, Ma N, Takata H, Yokoyama M, Uchiyama S, et al. Fibrillarin, a nucleolar protein, is required for normal nuclear morphology and cellular growth in HeLa cells. Biochem Biophys Res Commun. 2007;360(2):320\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1504_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/BJ20081411","volume":"415","author":"MA Amin","year":"2008","unstructured":"Amin MA, Matsunaga S, Uchiyama S, Fukui K. Depletion of nucleophosmin leads to distortion of nucleolar and nuclear structures in HeLa cells. Biochem J. 2008;415(3):345\u201351.","journal-title":"Biochem J"},{"issue":"9","key":"1504_CR55","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/cells8091035","volume":"8","author":"S Sleiman","year":"2019","unstructured":"Sleiman S, Dragon F. Recent advances on the structure and function of RNA acetyltransferase Kre33\/NAT10. Cells. 2019;8(9):1035.","journal-title":"Cells"},{"issue":"7","key":"1504_CR56","doi-asserted-by":"publisher","first-page":"112810","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang S, Han H, Wang X, Zheng S, Wang Z, et al. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Rep. 2023;42(7):112810.","journal-title":"Cell Rep"},{"issue":"10","key":"1504_CR57","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.yexcr.2009.03.007","volume":"315","author":"Q Shen","year":"2009","unstructured":"Shen Q, Zheng X, McNutt MA, Guang L, Sun Y, Wang J, et al. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res. 2009;315(10):1653\u201367.","journal-title":"Exp Cell Res"},{"issue":"6183","key":"1504_CR58","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu D, Britton S, Demir M, Rodriguez R. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014;344(6183):527\u201332.","journal-title":"Science"},{"key":"1504_CR59","doi-asserted-by":"publisher","first-page":"121149","DOI":"10.1016\/j.envpol.2023.121149","volume":"322","author":"W Shenshen","year":"2023","unstructured":"Shenshen W, Yin L, Han K, Jiang B, Meng Q, Aschner M, et al. NAT10 accelerates pulmonary fibrosis through N4-acetylated TGFB1-initiated epithelial-to-mesenchymal transition upon ambient fine particulate matter exposure. Environ Pollut. 2023;322:121149.","journal-title":"Environ Pollut"},{"key":"1504_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","volume":"32","author":"L Xie","year":"2023","unstructured":"Xie L, Zhong X, Cao W, Liu J, Zu X, Chen L. Mechanisms of NAT10 as ac4c writer in diseases. Mol Therapy Nucleic Acids. 2023;32:359\u201368.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"5","key":"1504_CR61","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/emmm.201201823","volume":"7","author":"TZ Tan","year":"2013","unstructured":"Tan TZ, Miow QH, Huang RY, Wong MK. Functional genomics identifies five distinct molecular subtypes with clinical relevance and. EMBO Mol Med. 2013;7(5):1051\u201366.","journal-title":"EMBO Mol Med"},{"issue":"17","key":"1504_CR62","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-13-3477","volume":"20","author":"H Zhang","year":"2014","unstructured":"Zhang H, Hou W, Wang H, Liu H, Jia X, Zheng X, et al. GSK-3\u03b2\u2013regulated n-acetyltransferase 10 is involved in colorectal cancer invasion. Clin Cancer Res. 2014;20(17):4717\u201329.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1504_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","volume":"33","author":"L Liao","year":"2023","unstructured":"Liao L, He Y, Li S, Yu X. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 2023;33(5):355\u201371.","journal-title":"Cell Res"},{"issue":"1","key":"1504_CR64","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11010-006-9390-5","volume":"300","author":"H Liu","year":"2007","unstructured":"Liu H, Ling Y, Gong Y. DNA damage induces N-acetyltransferase NAT10 gene expression through transcriptional activation. Mol Cell Biochem. 2007;300(1):249\u201358.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1504_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022;41(1):345.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1504_CR66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-025-03277-y","volume":"44","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Song D, Guo M, Wang C, Ma M, Tao G, et al. EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in colorectal cancer. J Exp Clin Cancer Res. 2025;44(1):37.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"1504_CR67","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7150\/ijms.83828","volume":"20","author":"Y Long","year":"2023","unstructured":"Long Y, Ren Y, Wei Q, Mobet Y, Liu Y, Zhao H, et al. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression. Int J Med Sci. 2023;20(8):1079\u201390.","journal-title":"Int J Med Sci"},{"issue":"11","key":"1504_CR68","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1111\/cas.15946","volume":"114","author":"Y Liu","year":"2023","unstructured":"Liu Y, Huang H, Zhang CB, Fan HN. N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA. Cancer Sci. 2023;114(11):4202\u201315.","journal-title":"Cancer Sci"},{"key":"1504_CR69","doi-asserted-by":"publisher","first-page":"139823","DOI":"10.1016\/j.ijbiomac.2025.139823","volume":"297","author":"N Xiao","year":"2025","unstructured":"Xiao N, Liu H, Zhang R, Li Y, Zhao X, Chen H, et al. N-acetyltransferase 10 impedes EZH2\/H3K27me3\/GABARAP axis mediated autophagy and facilitates lung cancer tumorigenesis through enhancing SGK2 mRNA acetylation. Int J Biol Macromol. 2025;297:139823.","journal-title":"Int J Biol Macromol"},{"issue":"15","key":"1504_CR70","doi-asserted-by":"publisher","first-page":"2411834","DOI":"10.1002\/advs.202411834","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang H, Zhao B, Zhang J, Hu Q, Zhou L, Zhang Y, et al. N4-acetylcytidine-mediated CD2BP2-DT drives YBX1 phase separation to stabilize CDK1 and promote breast cancer progression. Adv Sci. 2025;12(15):2411834.","journal-title":"Adv Sci"},{"issue":"38","key":"1504_CR71","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1038\/s41388-024-03133-x","volume":"43","author":"S Gong","year":"2024","unstructured":"Gong S, Qiao H, Wang J, Huang S, He S, Zhao Y, et al. Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4\/ITGA6 translation. Oncogene. 2024;43(38):2868\u201384.","journal-title":"Oncogene"},{"issue":"1","key":"1504_CR72","doi-asserted-by":"publisher","first-page":"2274143","DOI":"10.1080\/15384047.2023.2274143","volume":"24","author":"Z Li","year":"2023","unstructured":"Li Z, Li D, Yang T, Yao C. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA. Cancer Biol Ther. 2023;24(1):2274143.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1504_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin W, et al. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6(1):173.","journal-title":"Signal Transduct Target Ther"},{"key":"1504_CR74","doi-asserted-by":"publisher","first-page":"111014","DOI":"10.1016\/j.cellsig.2023.111014","volume":"116","author":"D Liu","year":"2024","unstructured":"Liu D, Yang X, Wang X. Neutrophil extracellular traps promote gastric cancer cell metastasis via the NAT10-mediated N4-acetylcytidine modification of SMYD2. Cell Signal. 2024;116:111014.","journal-title":"Cell Signal"},{"issue":"3","key":"1504_CR75","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cac2.12523","volume":"44","author":"D Miao","year":"2024","unstructured":"Miao D, Shi J, Lv Q, Tan D, Zhao C, Xiong Z, et al. NAT10-mediated ac4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer Commun. 2024;44(3):361\u201383.","journal-title":"Cancer Commun"},{"issue":"11","key":"1504_CR76","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41419-023-06245-6","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang X, Liu Y, Yang J, Mao W, Feng C, et al. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK\/ERK signaling pathway. Cell Death Dis. 2023;14(11):712.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1504_CR77","doi-asserted-by":"publisher","first-page":"113620","DOI":"10.1016\/j.yexcr.2023.113620","volume":"428","author":"G Zong","year":"2023","unstructured":"Zong G, Wang X, Guo X, Zhao Q, Wang C, Shen S, et al. NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression. Exp Cell Res. 2023;428(2):113620.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1504_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12905-025-03567-9","volume":"25","author":"Y Song","year":"2025","unstructured":"Song Y, Cheng M. NAT10 promotes ovarian cancer cell migration, invasion, and stemness via N4-acetylcytidine modification of CAPRIN1. BMC Womens Health. 2025;25(1):54.","journal-title":"BMC Womens Health"},{"key":"1504_CR79","doi-asserted-by":"publisher","first-page":"967811","DOI":"10.3389\/fonc.2022.967811","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Deng Z, Sun S, Xie S, Jiang M, Chen B, et al. NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway. Front Oncol. 2022;12:967811.","journal-title":"Front Oncol"},{"issue":"12","key":"1504_CR80","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 2022;42(12):1347\u201366.","journal-title":"Cancer Commun"},{"issue":"10","key":"1504_CR81","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1111\/cas.16249","volume":"115","author":"Z Xue","year":"2024","unstructured":"Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W, et al. NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Sci. 2024;115(10):3256\u201372.","journal-title":"Cancer Sci"},{"issue":"5","key":"1504_CR82","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/antiox12051116","volume":"12","author":"MH Dalhat","year":"2023","unstructured":"Dalhat MH, Choudhry H, Khan MI. NAT10, an RNA cytidine acetyltransferase, regulates ferroptosis in cancer cells. Antioxidants. 2023;12(5):1116.","journal-title":"Antioxidants"},{"issue":"10","key":"1504_CR83","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 2023;83(10):1666\u201383.","journal-title":"Cancer Res"},{"issue":"1","key":"1504_CR84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13072-023-00501-x","volume":"16","author":"A Svobodov\u00e1 Kova\u0159\u00edkov\u00e1","year":"2023","unstructured":"Svobodov\u00e1 Kova\u0159\u00edkov\u00e1 A, Stixov\u00e1 L, Kova\u0159\u00edk A, B\u00e1rtov\u00e1 E. PARP-dependent and NAT10-independent acetylation of N4-cytidine in RNA appears in UV-damaged chromatin. Epigenetics Chromatin. 2023;16(1):26.","journal-title":"Epigenetics Chromatin"},{"issue":"2","key":"1504_CR85","doi-asserted-by":"publisher","first-page":"e010301","DOI":"10.1136\/jitc-2024-010301","volume":"13","author":"H Xie","year":"2025","unstructured":"Xie H, Zhang K, Yin H, Zhang S, Pan S, Wu R, et al. Acetyltransferase NAT10 inhibits T-cell immunity and promotes nasopharyngeal carcinoma progression through DDX5\/HMGB1 axis. J Immunother Cancer. 2025;13(2):e010301.","journal-title":"J Immunother Cancer"},{"key":"1504_CR86","doi-asserted-by":"publisher","first-page":"112317","DOI":"10.1016\/j.intimp.2024.112317","volume":"135","author":"Q Li","year":"2024","unstructured":"Li Q, Yuan Z, Wang Y, Zhai P, Wang J, Zhang C, et al. Unveiling YWHAH: a potential therapeutic target for overcoming CD8+ T cell exhaustion in colorectal cancer. Int Immunopharmacol. 2024;135:112317.","journal-title":"Int Immunopharmacol"},{"key":"1504_CR87","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.tranon.2024.101934","volume":"45","author":"C Jin","year":"2024","unstructured":"Jin C, Gao J, Zhu J, Ao Y, Shi B, Li X. Exosomal NAT10 from esophageal squamous cell carcinoma cells modulates macrophage lipid metabolism and polarization through ac4C modification of FASN. Transl Oncol. 2024;45:101934.","journal-title":"Transl Oncol"},{"issue":"1","key":"1504_CR88","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41420-024-01997-2","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang Z, Luo J, Huang H, Wang L, Lv T, Wang Z, et al. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis. Cell Death Discov. 2024;10(1):240.","journal-title":"Cell Death Discov"},{"key":"1504_CR89","doi-asserted-by":"publisher","first-page":"1448890","DOI":"10.3389\/fonc.2024.1448890","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Zeng Y, Zhang Y, Zhu Y, Xu S, Liang Z. Acetylcytidine modification of DDX41 and ZNF746 by N -acetyltransferase 10 contributes to chemoresistance of melanoma. Front Oncol. 2024;14:1448890.","journal-title":"Front Oncol"},{"issue":"10","key":"1504_CR90","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/1759-7714.15262","volume":"15","author":"CC Zhao","year":"2024","unstructured":"Zhao CC, Sun X, Chen J, Geng BD. NAT10 -mediatedmRNA N4 -acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. Thorac Cancer. 2024;15(10):820\u20139.","journal-title":"Thorac Cancer"},{"issue":"19","key":"1504_CR91","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.7150\/jca.101403","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wang L, He C, Liu Z, Fu R, Xie Y. NAT10 mediates XPO1 mRNA N4-acetylation and promotes drug resistance of myeloma cells. J Cancer. 2024;15(19):6355\u201363.","journal-title":"J Cancer"},{"issue":"9","key":"1504_CR92","doi-asserted-by":"publisher","first-page":"e30330","DOI":"10.1016\/j.heliyon.2024.e30330","volume":"10","author":"L Gao","year":"2024","unstructured":"Gao L, Li T, Yang S, Ma H, Wang X, Zhang D. NAT10-mediated ac4C modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8. Heliyon. 2024;10(9):e30330.","journal-title":"Heliyon"},{"issue":"6","key":"1504_CR93","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.7150\/thno.104310","volume":"15","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li M, Chen C, Xu L, Fu Y, Xu J, et al. Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis. Theranostics. 2025;15(6):2428\u201350.","journal-title":"Theranostics"},{"issue":"32","key":"1504_CR94","doi-asserted-by":"publisher","first-page":"e2302705","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, et al. NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer. Adv Sci (Weinh). 2023;10(32):e2302705.","journal-title":"Adv Sci (Weinh)"},{"issue":"48","key":"1504_CR95","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li J, Xu J, Long Y, Wang Y, Liu X, et al. M6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncogene. 2024;43(48):3498\u2013516.","journal-title":"Oncogene"},{"issue":"7","key":"1504_CR96","doi-asserted-by":"publisher","first-page":"e1747","DOI":"10.1002\/ctm2.1747","volume":"14","author":"M Ding","year":"2024","unstructured":"Ding M, Yu Z, Lu T, Hu S, Zhou X, Wang X. N -acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK\/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clin Transl Med. 2024;14(7):e1747.","journal-title":"Clin Transl Med"},{"issue":"9","key":"1504_CR97","doi-asserted-by":"publisher","first-page":"101728","DOI":"10.1016\/j.xcrm.2024.101728","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou Y, Guo S, Wen L, Lv D, Tu J, Liao Y, et al. Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Rep Med. 2024;5(9):101728.","journal-title":"Cell Rep Med"},{"issue":"3","key":"1504_CR98","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15252\/embr.201540505","volume":"17","author":"X Liu","year":"2016","unstructured":"Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17(3):349\u201366.","journal-title":"EMBO Rep"},{"issue":"1","key":"1504_CR99","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12885-017-3570-4","volume":"17","author":"Q Li","year":"2017","unstructured":"Li Q, Liu X, Jin K, Lu M, Zhang C, Du X, et al. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity. BMC Cancer. 2017;17(1):605.","journal-title":"BMC Cancer"},{"issue":"7","key":"1504_CR100","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Su K, Wang C, Deng T, Liu X, Sun S, et al. Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma. Cell Death Dis. 2024;15(7):545.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1504_CR101","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-022-01338-9","volume":"15","author":"Z Feng","year":"2022","unstructured":"Feng Z, Li K, Qin K, Liang J. The LINC00623\/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modifcation of mRNA. J Hematol Oncol. 2022;15(1):112.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1504_CR102","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/21691401.2019.1709852","volume":"48","author":"Y Fan","year":"2020","unstructured":"Fan Y, Sheng W, Meng Y, Cao Y, Li R. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b. Artif Cells Nanomed Biotechnol. 2020;48(1):393\u2013407.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"1504_CR103","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/1878-0261.12472","volume":"13","author":"V M\u00fcller","year":"2019","unstructured":"M\u00fcller V, Oliveira-Ferrer L, Steinbach B, Pantel K. Interplay of lncRNA H19\/miR-675 and lncRNA NEAT1\/miR-204 in breast cancer. Mol Oncol. 2019;13(5):1137\u201349.","journal-title":"Mol Oncol"},{"issue":"1","key":"1504_CR104","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1515\/med-2022-0583","volume":"17","author":"C Du","year":"2022","unstructured":"Du C, Han X, Zhang Y, Guo F, Yuan H, Wang F, et al. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p\/NAT10 axis. Open Med. 2022;17(1):2036\u201345.","journal-title":"Open Med"},{"key":"1504_CR105","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.2147\/CMAR.S197733","volume":"11","author":"Z Liu","year":"2019","unstructured":"Liu Z, Liu X, Li Y, Ren P, Zhang C, Wang L, et al. MiR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression. Cancer Manag Res. 2019;11:5317\u201332.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"1504_CR106","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s13353-024-00840-9","volume":"65","author":"S Wang","year":"2024","unstructured":"Wang S, Li Q, Wang Y, Li X, Feng X, Wei Y, et al. Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification. J Appl Genet. 2024;65(4):797\u2013807.","journal-title":"J Appl Genet"},{"issue":"1","key":"1504_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s11658-024-00540-6","volume":"29","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yuan L, Zou Q, Shao C, Jia Y, Li J, et al. CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA. Cell Mol Biol Lett. 2024;29(1):25.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1504_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41419-023-06373-z","volume":"15","author":"Y Shuai","year":"2024","unstructured":"Shuai Y, Zhang H, Liu C, Wang J, Jiang Y, Sun J, et al. CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression. Cell Death Dis. 2024;15(1):9.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1504_CR109","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12032-022-01736-6","volume":"39","author":"Z Wang","year":"2022","unstructured":"Wang Z, Huang Y, Lu W. C-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer. Med Oncol. 2022;39(10):140.","journal-title":"Med Oncol"},{"issue":"7","key":"1504_CR110","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.cell.2018.11.037","volume":"175","author":"D Dominissini","year":"2018","unstructured":"Dominissini D, Rechavi G. N4-acetylation of cytidine in mRNA by NAT10 regulates stability and translation. Cell. 2018;175(7):1725\u20137.","journal-title":"Cell"},{"issue":"6","key":"1504_CR111","doi-asserted-by":"publisher","first-page":"e17103","DOI":"10.1016\/j.heliyon.2023.e17103","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang W, Gao J, Fan L, Wang J, He B, Wang Y, et al. Ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma. Heliyon. 2023;9(6):e17103.","journal-title":"Heliyon"},{"key":"1504_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3570-4","author":"Q Li","year":"2017","unstructured":"Li Q, Liu X, Jin K. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity. BMC Cancer. 2017. https:\/\/doi.org\/10.1186\/s12885-017-3570-4.","journal-title":"BMC Cancer"},{"issue":"12","key":"1504_CR113","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.3390\/ijms23126573","volume":"23","author":"N Ma","year":"2022","unstructured":"Ma N, Liu H, Wu Y, Yao M, Zhang B. Inhibition of N-acetyltransferase 10 suppresses the progression of prostate cancer through regulation of DNA replication. Int J Mol Sci. 2022;23(12):6573.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1504_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","volume":"34","author":"MB Fuertes","year":"2013","unstructured":"Fuertes MB, Woo S, Burnett B, Fu Y, Gajewski TF. Type I interferon response and innate immune sensing of cancer. Trends Immunol. 2013;34(2):67\u201373.","journal-title":"Trends Immunol"},{"issue":"4","key":"1504_CR115","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbrc.2018.04.047","volume":"499","author":"Y Tan","year":"2018","unstructured":"Tan Y, Zheng J, Liu X, Lu M, Zhang C, Xing B, et al. Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma. Biochem Biophys Res Commun. 2018;499(4):1032\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1504_CR116","doi-asserted-by":"publisher","first-page":"1133166","DOI":"10.3389\/fimmu.2023.1133166","volume":"14","author":"X Dong","year":"2023","unstructured":"Dong X, Huang K, Chen Y, Yang F, Cunbing X, Yang AH. Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. Front Immunol. 2023;14:1133166.","journal-title":"Front Immunol"},{"issue":"1","key":"1504_CR117","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12935-021-02124-2","volume":"21","author":"W Tao","year":"2021","unstructured":"Tao W, Tian G, Xu S. NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC. Cancer Cell Int. 2021;21(1):413.","journal-title":"Cancer Cell Int"},{"key":"1504_CR118","doi-asserted-by":"publisher","first-page":"115628","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo J, Cao J, Chen C, Xie H. Emerging role of RNA acetylation modification ac4C in diseases: current advances and future challenges. Biochem Pharmacol. 2023;213:115628.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"1504_CR119","first-page":"14765","volume":"8","author":"X Zhang","year":"2015","unstructured":"Zhang X, Liu J, Yan S, Huang K. High expression of n-acetyltransferase 10 a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(11):14765\u201371.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"1504_CR120","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","volume":"26","author":"S Zhang","year":"2024","unstructured":"Zhang S, Huang F, Wang Y, Long Y, Li Y, Kang Y, et al. NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. Nat Cell Biol. 2024;26(12):2168\u201382.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1504_CR121","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41418-021-00899-5","volume":"29","author":"J Zheng","year":"2022","unstructured":"Zheng J, Tan Y, Liu X, Zhang C, Su K, Jiang Y, et al. NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation. Cell Death Differ. 2022;29(4):846\u201360.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1504_CR122","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.1038\/s41598-021-84908-0","volume":"11","author":"MH Dalhat","year":"2021","unstructured":"Dalhat MH, Altayb HN, Khan MI, Choudhry H. Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors. Sci Rep. 2021;11(1):6010\u201351.","journal-title":"Sci Rep"},{"issue":"1","key":"1504_CR123","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L, Ma R, Cai J. RNA modifications importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7(1):334.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01504-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T13:58:11Z","timestamp":1764338291000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01504-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1504"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01504-9","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}